title: The active monomeric form of macrophage inflammatory protein-1 alpha interacts with high- and low-affinity classes of receptors on human hematopoietic cells.
abstract: Macrophage inflammatory protein-1 alpha (MIP-1 alpha) and its human homologue GOS19.1/LD78 are members of the C-C chemokine/intercrine family of secreted proteins. They have proinflammatory properties and also inhibit cell cycle progression of hematopoietic stem cells. Characterization of MIP-1 alpha receptor(s) has been confused because of its reported aggregation to inactive forms. Using a defined monomeric form of MIP-1 alpha that is biologically active for stem cell inhibition and induction of oxidative metabolism in polymorphonuclear cells, we report the detection of high- and low-affinity receptor classes on human leukemic CD34+ blast cells, promyelocytic cells, monocytes, peripheral blood neutrophils, and T cells. Both high- and low-affinity classes are expressed simultaneously in promyelocytes and neutrophils. The calculated kd for high-affinity receptors correlates with the concentrations of MIP-1 alpha required to induce a biologic effect on stem cells and neutrophils. Cross-linking studies show that MIP-1 alpha associates with two cell surface proteins with apparent molecular masses of 92 kD and 52 kD. Direct competition binding studies combined with studies on the inhibition of stem cells show that human and murine MIP-1 alpha have different receptor-binding and biologic properties.
authors.affiliation: Department of Internal Medicine, Ohio State University Hospitals, Columbus.
authors.forename: B R
authors.initials: BR
authors.lastname: Avalos
authors.forename: K J
authors.initials: KJ
authors.lastname: Bartynski
authors.forename: P J
authors.initials: PJ
authors.lastname: Elder
authors.forename: M S
authors.initials: MS
authors.lastname: Kotur
authors.forename: W G
authors.initials: WG
authors.lastname: Burton
authors.forename: N M
authors.initials: NM
authors.lastname: Wilkie
mesh_terms: D015703:Antigens, CD / Q000032:analysis; D018952:Antigens, CD34; D001667:Binding, Competitive; D054407:Chemokine CCL4; D003432:Cross-Linking Reagents; D016207:Cytokines / Q000378:metabolism*; D006098:Granulocytes / Q000378:metabolism; D006412:Hematopoietic Stem Cells / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D007938:Leukemia; D019402:Macrophage Inflammatory Proteins; D008970:Molecular Weight; D009000:Monocytes / Q000378:metabolism; D015846:Monokines / Q000378:metabolism*; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000378:metabolism; D019707:Receptors, Chemokine; D011971:Receptors, Immunologic / Q000378:metabolism*; D013601:T-Lymphocytes / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34; D054407:Chemokine CCL4; D003432:Cross-Linking Reagents; D016207:Cytokines; D019402:Macrophage Inflammatory Proteins; D015846:Monokines; D019707:Receptors, Chemokine; D011971:Receptors, Immunologic; C080633:macrophage inflammatory protein 1alpha receptor; D009240:N-Formylmethionine Leucyl-Phenylalanine; D013755:Tetradecanoylphorbol Acetate